A critical remaining question is the identification of an Nt-arginylation-permissive substrate that regulates caspase-1 protein levels via either transcription or degradation, thereby affecting RILP cleavage and its downstream exosome formation in cancer cells. The gene discussed is RILP; the disease is cancer.